- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ENvue Medical, Inc.: ENvue Medical to Showcase ENvue Navigation Platform at AACN NTI 2026 | 1 | GlobeNewswire (USA) | ||
| Mo | ENvue Medical, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.05. | ENvue Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 12.05. | ENvue Medical, Inc.: ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue Navigation Platform Becomes Standard of Care | 1 | GlobeNewswire (USA) | ||
| 12.05. | EXCLUSIVE: ENvue Medical Says Health System Renewal Extends Platform Adoption Through 2028 | 1 | Benzinga.com | ||
| 08.05. | ENvue Medical, Inc.: ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology | 1 | GlobeNewswire (USA) | ||
| 07.05. | ENvue Medical, Inc.: ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals | 307 | GlobeNewswire (Europe) | TYLER, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided... ► Artikel lesen | |
| 07.05. | EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028 | 2 | Benzinga.com | ||
| 20.04. | ENvue Medical, Inc.: ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network | 1 | GlobeNewswire (USA) | ||
| 16.04. | ENvue Medical reports 39 hospital deployments for navigation platform | 2 | Investing.com | ||
| 16.04. | ENvue Medical: Navigationsplattform in 39 US-Kliniken im Einsatz | 1 | Investing.com Deutsch | ||
| 16.04. | ENvue Medical, Inc.: ENvue Issues Stockholder Letter & Provides Corporate Update | 194 | GlobeNewswire (Europe) | TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent... ► Artikel lesen | |
| 15.04. | ENvue Medical, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 26.03. | What's Going On With ENvue Medical Stock On Thursday? | 2 | Benzinga.com | ||
| 24.03. | ENvue Medical Shares Jump 45% After Hospital Platform Expansion | 5 | RTTNews | ||
| 24.03. | ENvue Pops on Buying New Platform | - | Baystreet.ca | ||
| 24.03. | ENvue Medical erweitert US-Präsenz durch Verkauf an Krankenhaus in Detroit | 2 | Investing.com Deutsch | ||
| 24.03. | ENvue Medical, Inc.: ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39 | 10 | GlobeNewswire (USA) | ||
| 24.03. | EXCLUSIVE: ENvue's FDA-Cleared Tube Placement System Gains Traction In Critical Care Settings | 6 | Benzinga.com | ||
| 24.02. | ENvue Medical receives patent allowance for feeding tube technology | 6 | Investing.com |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 34,510 | +0,82 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 60 auf 50 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Mit der Sparte Bildgebende Verfahren... ► Artikel lesen | |
| BECTON DICKINSON | 126,15 | -0,16 % | BD unveils new laser system for kidney stone treatment | ||
| NUGEN MEDICAL DEVICES | 0,016 | +13,89 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| SPINEWAY | 0,130 | +2,20 % | Spineway: First-quarter 2026 revenue | Ecully, April 30, 2026 - 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change... ► Artikel lesen | |
| LIFEWARD | 6,280 | -3,24 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| NUWELLIS, INC | 0,970 | -0,81 % | Nuwellis, Inc.: Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label | MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces... ► Artikel lesen | |
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| GLUCOTRACK | 0,464 | -16,39 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| BONE BIOLOGICS | 1,230 | -2,38 % | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | ||
| MANGOCEUTICALS | 0,430 | +4,12 % | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | ||
| FRESENIUS | 39,910 | -0,65 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.05.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,770 | +0,68 % | Shortseller-Positionen aktuell: u.a. Evotec, FMC, Gerresheimer, Hypoport, Nagarro, Nordex, Suss MicroTec | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CO-DIAGNOSTICS | 3,705 | 0,00 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| GENEDX | 47,340 | +12,37 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BRIGHTSPRING HEALTH SERVICES | 58,01 | +2,27 % | BMO raises BrightSpring Health stock price target on generic drug outlook |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,06 % bei einem Aktienkurs von 0,930 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.